United States · FDA National Drug Code directory
RISPERDAL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50458-300_15ff9571-c82c-48d9-84d3-a7a6abaae93e
- Product NDC
- 50458-300
- Form
- TABLET
- Composition / generic term
- risperidone
- Labeler
- Janssen Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 19931229
- Source listing expiry
- 20271231
Source-listed ingredients
- RISPERIDONE — 1 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BLISTER PACK in 1 BOX, UNIT-DOSE (50458-300-01) / 10 TABLET in 1 BLISTER PACK · 50458-300-01
- 60 TABLET in 1 BOTTLE (50458-300-06) · 50458-300-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →